110 related articles for article (PubMed ID: 27744496)
1. The IKKα-dependent non-canonical pathway of NF-κB activation is constitutively active and modulates progression-related functions in a subset of human melanomas.
Dewert N; Amschler K; Lorenz V; Schön MP
Arch Dermatol Res; 2016 Dec; 308(10):733-742. PubMed ID: 27744496
[TBL] [Abstract][Full Text] [Related]
2. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
3. IKKα plays a major role in canonical NF-κB signalling in colorectal cells.
Prescott JA; Balmanno K; Mitchell JP; Okkenhaug H; Cook SJ
Biochem J; 2022 Feb; 479(3):305-325. PubMed ID: 35029639
[TBL] [Abstract][Full Text] [Related]
4. Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer.
Nottingham LK; Yan CH; Yang X; Si H; Coupar J; Bian Y; Cheng TF; Allen C; Arun P; Gius D; Dang L; Van Waes C; Chen Z
Oncogene; 2014 Feb; 33(9):1135-47. PubMed ID: 23455325
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin-induced activation of NF-κB in melanoma cells is abrogated by inhibition of IKKβ, but not by a novel IKKα inhibitor.
Pletz N; Schön M; Ziegelbauer K; Emmert S; Liu N; Dobbelstein M; Schön MP
Exp Dermatol; 2012 Apr; 21(4):301-4. PubMed ID: 22320445
[TBL] [Abstract][Full Text] [Related]
6. Maximal adamantyl-substituted retinoid-related molecule-induced apoptosis requires NF-κB noncanonical and canonical pathway activation.
Farhana L; Dawson MI; Murshed F; Fontana JA
Cell Death Differ; 2011 Jan; 18(1):164-73. PubMed ID: 20671747
[TBL] [Abstract][Full Text] [Related]
7. Nuclear factor-κB2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1α independent manner.
Yeramian A; Santacana M; Sorolla A; Llobet D; Encinas M; Velasco A; Bahi N; Eritja N; Domingo M; Oliva E; Dolcet X; Matias-Guiu X
Lab Invest; 2011 Jun; 91(6):859-71. PubMed ID: 21537326
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.
Luftig M; Yasui T; Soni V; Kang MS; Jacobson N; Cahir-McFarland E; Seed B; Kieff E
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):141-6. PubMed ID: 14691250
[TBL] [Abstract][Full Text] [Related]
9. TNF-α Modulation of Intestinal Tight Junction Permeability Is Mediated by NIK/IKK-α Axis Activation of the Canonical NF-κB Pathway.
Al-Sadi R; Guo S; Ye D; Rawat M; Ma TY
Am J Pathol; 2016 May; 186(5):1151-65. PubMed ID: 26948423
[TBL] [Abstract][Full Text] [Related]
10. Ikappa B kinase alpha involvement in the development of nasopharyngeal carcinoma through a NF-κB-independent and ERK-dependent pathway.
Xie Y; Li Y; Peng X; Henderson F; Deng L; Chen N
Oral Oncol; 2013 Dec; 49(12):1113-20. PubMed ID: 24075781
[TBL] [Abstract][Full Text] [Related]
11. TAK1 is critical for IkappaB kinase-mediated activation of the NF-kappaB pathway.
Takaesu G; Surabhi RM; Park KJ; Ninomiya-Tsuji J; Matsumoto K; Gaynor RB
J Mol Biol; 2003 Feb; 326(1):105-15. PubMed ID: 12547194
[TBL] [Abstract][Full Text] [Related]
12. Active roles for inhibitory kappaB kinases alpha and beta in nuclear factor-kappaB-mediated chemoresistance to doxorubicin.
Bednarski BK; Ding X; Coombe K; Baldwin AS; Kim HJ
Mol Cancer Ther; 2008 Jul; 7(7):1827-35. PubMed ID: 18644995
[TBL] [Abstract][Full Text] [Related]
13. Cell migration to CXCL12 requires simultaneous IKKα and IKKβ-dependent NF-κB signaling.
Penzo M; Habiel DM; Ramadass M; Kew RR; Marcu KB
Biochim Biophys Acta; 2014 Sep; 1843(9):1796-1804. PubMed ID: 24747690
[TBL] [Abstract][Full Text] [Related]
14. KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment.
Schön M; Wienrich BG; Kneitz S; Sennefelder H; Amschler K; Vöhringer V; Weber O; Stiewe T; Ziegelbauer K; Schön MP
J Natl Cancer Inst; 2008 Jun; 100(12):862-75. PubMed ID: 18544741
[TBL] [Abstract][Full Text] [Related]
15. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.
Senftleben U; Cao Y; Xiao G; Greten FR; Krähn G; Bonizzi G; Chen Y; Hu Y; Fong A; Sun SC; Karin M
Science; 2001 Aug; 293(5534):1495-9. PubMed ID: 11520989
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB inhibition through proteasome inhibition or IKKbeta blockade increases the susceptibility of melanoma cells to cytostatic treatment through distinct pathways.
Amschler K; Schön MP; Pletz N; Wallbrecht K; Erpenbeck L; Schön M
J Invest Dermatol; 2010 Apr; 130(4):1073-86. PubMed ID: 19940859
[TBL] [Abstract][Full Text] [Related]
17. IKKalpha controls p52/RelB at the skp2 gene promoter to regulate G1- to S-phase progression.
Schneider G; Saur D; Siveke JT; Fritsch R; Greten FR; Schmid RM
EMBO J; 2006 Aug; 25(16):3801-12. PubMed ID: 16902410
[TBL] [Abstract][Full Text] [Related]
18. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
[TBL] [Abstract][Full Text] [Related]
19. Notch3 and pre-TCR interaction unveils distinct NF-kappaB pathways in T-cell development and leukemia.
Vacca A; Felli MP; Palermo R; Di Mario G; Calce A; Di Giovine M; Frati L; Gulino A; Screpanti I
EMBO J; 2006 Mar; 25(5):1000-8. PubMed ID: 16498412
[TBL] [Abstract][Full Text] [Related]
20. Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression.
Remels AH; Gosker HR; Langen RC; Polkey M; Sliwinski P; Galdiz J; van den Borst B; Pansters NA; Schols AM
Biochim Biophys Acta; 2014 Feb; 1842(2):175-85. PubMed ID: 24215713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
